First Interchangeable Biosimilar Insulin for Diabetes Treatment Approved
Time to read: 01:00. The U.S. Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for the improvement of glycaemic control in both adults and paediatric patients with diabetes mellitus
Source: FDA Press Release, PR NewsWire
Feature
Text
FDA approves first drug to delay type 1 diabetes
The FDA has approved Tzield® (teplizumab-mzwv) for use in adult patients with stage 3 type 1 diabetes and in paediatric patients eight years and older with stage 2 type 1 diabetes.
Source: FDA Press Release
Text
MNDD002_Neuralace Medical Announces FDA Clearance of Axon Therapy for Chronic Painful Diabetic Neuropathy
The FDA has approved AXON, the first non-invasive, magnetic peripheral nerve stimulation (PNS) device for treating Diabetic Neuropathy (DN) pain.
Source: Neuralace Medical
Text
